Platelet Inhibition, Endothelial Function, and Clinical Outcome in Patients Presenting With ST‐Segment–Elevation Myocardial Infarction Randomized to Ticagrelor Versus Prasugrel Maintenance Therapy: Long‐Term Follow‐Up of the REDUCE‐MVI Trial

BACKGROUND: Off‐target properties of ticagrelor might reduce microvascular injury and improve clinical outcome in patients with ST‐segment–elevation myocardial infarction. The REDUCE‐MVI (Evaluation of Microvascular Injury in Revascularized Patients with ST‐Segment–Elevation Myocardial Infarction Tr...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Hoeven, Nina W., Janssens, Gladys N., Everaars, Henk, Nap, Alexander, Lemkes, Jorrit S., de Waard, Guus A., van de Ven, Peter M., van Rossum, Albert C., Escaned, Javier, Mejia‐Renteria, Hernan, ten Cate, Tim J. F., Piek, Jan J., von Birgelen, Clemens, Valgimigli, Marco, Diletti, Roberto, Riksen, Niels P., Van Mieghem, Nicolas M., Nijveldt, Robin, van Leeuwen, Maarten A. H., van Royen, Niels
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335553/
https://www.ncbi.nlm.nih.gov/pubmed/32122216
http://dx.doi.org/10.1161/JAHA.119.014411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335553/
https://www.ncbi.nlm.nih.gov/pubmed/32122216
http://dx.doi.org/10.1161/JAHA.119.014411

Ejemplares similares